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Purpose: Late graft failure is a critical problem, particularly in the presence of poor
runoff vessels. Intimal hyperplasia is considered to be the main cause of graft failure. We
have already reported that intimal thickening of experimental vein grafts in dogs with
poor runoff vessels is more pronounced than that in dogs with normal vessels. We and
others also have reported that production of nitric oxide (NO) in the endothelium of
canine vein grafts is impaired. In the present study, we asked whether in vivo gene trans-
fer of endothelial cell NO synthase (ecNOS) would inhibit intimal hyperplasia of auto-
genous vein grafts implanted in limbs with poor distal runoff in dogs.
Methods: After exposing femoral veins, the nuclear-targeted lac Z gene, bovine ecNOS cDNA,
or control vector plasmid encapsulated in the hemagglutinating virus of Japan-liposomes
was infused intraluminally, followed by incubation for 10 minutes at room temperature
under a distending pressure of 100 mm Hg. Twenty reversed vein grafts were implanted
under normal runoff conditions, and 4 days later these were used to confirm gene transfer
to the vein grafts. Twelve reversed vein grafts were implanted under conditions of poor
runoff, and 4 weeks after the operation intimal thickening was evident.
Results: In vein grafts under normal runoff conditions, lac Z gene transfer exhibited dif-
fuse and frequent X-Gal-positive signals in both medial and adventitial layers 4 days after
implantation (n = 3). In case of the ecNOS gene–transferred vein grafts, bovine ecNOS
protein was mainly detected in medial smooth muscle cells and adventitial cells 4 days after
implantation, determined using immunohistochemical techniques and bovine ecNOS spe-
cific antibody (n = 3). In addition, ecNOS-transferred vessels showed intense purple sig-
nals by reduced nicotinamide adenine dinucleotide phosphate diaphorase and nitroblue
tetrazolium reaction, in both medial and adventitial layers, whereas weak NOS activity was
recognized at the adventitial vasa vasorum of the untreated veins or control vector trans-
ferred veins (n = 3, respectively). In vein grafts under poor runoff conditions, the intimal
thickness at 4 weeks after implantation was significantly reduced by ecNOS gene transfer
(n = 4; 90.0 ± 7.6 mm and 1.18 ± 0.07 mm2) in comparison with buffer-treated vessels (n
= 4; 195.8 ± 25.7 mm and 2.62 ± 0.48 mm2) or vector vehicle–treated vessels (n = 4; 193.0
± 15.8 mm and 2.65 ± 0.22 mm2).
Conclusions: Our findings show that gene transfer of ecNOS inhibited intimal hyperpla-
sia of canine vein grafts caused by poor runoff conditions, as a result of an increased
local production of NO. Thus ecNOS gene transfer warrants further study as a possible
approach to prevent late graft failure. (J Vasc Surg 1998;27:135-44.)
An autologous vein graft is the most suitable,
available conduit for reconstruction in cases of arte-
rial occlusive disease.1 In the early postoperative
period after graft replacement, in addition to techni-
cal difficulties, acute platelet thrombosis may fre-
quently lead to graft occlusion. Late graft occlusion
follows either intimal hyperplasia or progression of
an underlying atherosclerotic vascular disease.2,3 In
particular, in poor runoff vessels late graft failure is
frequent.4-7
Endothelium-derived relaxing factor (EDRF),
that is, nitric oxide (NO),8 is a potent vasodilator
and also inhibits leukocyte-endothelial interac-
tion,9,10 platelet adhesion and aggregation,11-13 and
vascular smooth muscle proliferation.14 We and oth-
ers noted impairment of endothelium-dependent
relaxation in vein grafts in rabbits15,16 and dogs.17,18
In addition, we demonstrated that in poor runoff
conditions,19 which are linked to clinical late graft
failure,6,19 prostacyclin (PGI2) production20 and
NO production were impaired in canine vein grafts.21
These observations mean that endothelial dysfunc-
tion, under poor runoff conditions, may be one expla-
nation for the development of severe intimal hyper-
plasia of the vein graft. On the other hand, recent
studies concerning the dietary administration of L-
arginine, the substrate for NO synthase (NOS), inhib-
ited atherosclerotic lesions22 and intimal thickening of
rabbit vein grafts.23 Because a relationship may exist
between NO and intimal thickening in vein grafts, it
may be that overproduction of NO, as induced by for-
eign ecNOS gene transfer, would be a reasonable
approach to avoid excess intimal formation.
In vivo gene transfer techniques provide direct
and local effects of exogenously transfected genes.
von der Layen et al.24 reported that gene transfer of
endothelial cell–type NOS (ecNOS) inhibited inti-
mal hyperplasia in a rat balloon injury model.
However, little information is available on effects of
gene transfer of ecNOS on intimal thickening of vein
grafts in the canine poor runoff models.
In the present study, we first assessed the appro-
priate conditions, especially distending pressure, for
effective gene transfer to canine vein grafts, using
the nuclear targeted lac Z gene and the highly effi-
cient hemagglutinating virus of Japan (HVJ)-lipo-
some–mediated gene transfer technique.25 We first
introduced in canine vein grafts, bovine ecNOS
cDNA, driven by the strong eukaryotic promotor,
CAG hybrid promotor,26 then we investigated
whether the local overproduction of NO would
inhibit neointimal development of vein grafts
implanted under conditions of poor runoff.19
MATERIAL AND METHODS
Animals
Thirty-two adult mongrel dogs of either sex,
weighing from 10 to 15 kg, were subjected to graft
operations. All of the following procedures were
performed using sterile techniques and with use of a
general anesthetic, 30 mg/kg sodium pentobarbital,
given by intravenous injection plus maintenance
dosages as required. After termination of graft place-
ment, cephalosporin (100 mg/kg) was given by
intravenous injection. Systemic heparinization was
not done.
These animal experiments were reviewed by the
Ethics Committee on Animal Experiments in the
Faculty of Medicine, Kyushu University, and were
carried out under Guidelines for Animal
Experiments used by the Faculty of Medicine,
Kyushu University and The Law (No. 105) and
Notification (No. 6) of the Japanese Government.
The “Principles of Laboratory Animal Care” and the
Guide for the Care and Use of Laboratory Animals
JOURNAL OF VASCULAR SURGERY
136 Matsumoto et al. January 1998
Fig. 1. Dissecting microscopic (a and b) and light micro-
scopic (c) findings in pAct-NLS-lac Z gene-transferred
canine vein grafts under 100 mm Hg of distending pres-
sure. Vessel segments were harvested 4 days after gene
transfer and reacted with X-Gal solution. a, Intense blue
stain is diffusely visible on graft wall, whereas no apparent
positive signal is recognized on host artery. Original mag-
nification, ´6. b, High-powered view of X-Gal–stained
graft wall. Intense blue signal is detected in all layers of
vein graft. Original magnification, ´18. c, Light micro-
scopic findings of X-Gal–stained canine vein graft, the
same one as a and b. Intense blue stain is visible in both
medial (m) and adventitial (ad) layer. Counterstained with
nuclear fast red. Original magnification, ´200.
(NIH Publication No. 86-23, revised 1985) were
also followed.
Operative procedures
Vein bypass under normal runoff conditions.
Twenty reversed vein grafts were implanted in the
right hind limb of 20 dogs under normal runoff
conditions. With the dog under satisfactory anesthe-
sia, a 4 cm segment of femoral vein was exposed and
interposed into the femoral artery in an end-to-end
fashion with 7-0 polypropylene monofilament
sutures after the gene transfer procedures, as
described below. The grafts were harvested 4 days
later and were examined for X-Gal staining (lac Z
gene transfer; n = 5), reduced nicotinamide adenine
dinucleotide phosphate (NADPH) assay (buffer
treatment, n = 3; mock transfection, n = 3; and
ecNOS gene transfer, n = 3, respectively), immuno-
histochemical analysis (buffer treatment, n = 2;
mock transfection, n = 2; and ecNOS gene transfer,
n = 2, respectively).
Vein bypass under conditions of poor runoff.
A canine poor-runoff model (n = 12) was prepared as
described.19 Namely, all tributary arteries distal to
the saphenous artery in the unilateral posterior limb
were ligated and severed, except for a superior branch
of the posterior femoral artery. Thus a condition of
poor runoff was completed at the femoral artery.
Four weeks after the first surgical procedure, the
collateral vessels were fully developed in the right
hind limb (the poor-runoff limb).19,20 The femoral
artery and vein were then exposed at a site proximal
to the previous operation, and a 4 cm segment of
femoral vein was interposed into the femoral artery
in an end-to-end fashion with 7-0 polypropylene
monofilament sutures just after gene transfer. The
12 animals were separated into three groups of four
(buffer treatment, n = 4; mock transfection, n = 4;
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Fig. 2. Immunohistochemical detection of bovine endothelial cell nitric oxide (ecNOS) in
pUC-CAGGS-ecNOS gene-transferred canine vein graft. Vessel segments were harvested 4
days after gene transfer and fixed with neutralized 10% formaldehyde. Five mm thin sections
embedded in paraffin were examined immunohistochemically. Original magnification, ´100.
Counterstained with methyl green. a, Immunohistochemical localization of bovine ecNOS
protein in canine vein graft treated with pUC-CAGGS-ecNOS. Frequent positive signals are
recognized in medial and adventitial cells (arrows). b, Serial section that was reacted with non-
immunized rabbit serum, as a primary antibody for the negative control. No signal was
observed. c, Mock transfected (pUCCAGGS control vector transferred) canine vein graft
reacted with antibovine ecNOS antibody. No signal was observed.
and ecNOS gene transfer, n = 4, respectively). Four
weeks after the vein bypass procedure, vein grafts taken
from the midportion were studied histologically.
Assessment of hemodynamics
In previous studies, we found a close correlation
between the outcome of the reconstructed arteries
and intraoperative blood flow waveforms.27,28 In
terms of the intraluminal velocity profile, we ana-
lyzed flow waveforms and found that normal flow
waveform patterns were characterized by a remark-
able fluctuation of flow in the boundary layer adja-
cent to the vessel wall, whereas in the abnormal flow
waveforms stagnation of flow was seen in the
boundary layer.29,30 Namely, changes in flow in the
boundary layer adjacent to the vessel wall were
greater in the normal flow group as compared with
findings in the abnormal flow group. Thus we pre-
pared flow waveforms using an integral of time dif-
ferential of wall shear stress in a cardiac cycle (shear
stress variation, t-variation).29
Before harvesting the vein grafts 4 weeks after
operation, a flow probe connected to an electro-
magnetic flowmeter was applied on the femoral
artery to obtain the mean blood flow rate and flow
waveforms were recorded. The recorded waveforms
were traced using a digitizer (K-150, Kanto Denshi
Co., Tokyo) connected to a personal computer (PC-
9801RX, Nippon Electric Company, Tokyo), which
displayed a computational simulated intraluminal
velocity file, and we calculated wall shear stress adja-
cent to the vessel wall and the integral of time dif-
ferential of the wall shear stress in a cardiac cycle
(shear stress variation, t-variation). The computa-
tional method was based on the assumption that (1)
blood is a Newtonian fluid and (2) vessels to be
studied are rigid, straight, long tubes. A detailed
description of the method has been documented.30
Plasmid construct
The lac Z gene with nuclear-targeted signal of
SV40 large T antigen used in this study was kindly
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Fig. 3. NADPH diaphorase assay for vein graft. Vessel segments, harvested 4 days after gene
transfer, were irrigated with phosphate-buffered saline solution and immediately reacted in
NADPH solution for 30 minutes at 37° C. Reaction was stopped by washing with phosphate
buffered saline solution followed by fixation with neutralized 10% formaldehyde. This experi-
ment was repeated three times and produced similar results. a, Dissecting microscopic findings
in untreated control vein. Weak and vague blue stain is visible around luminal surface, indi-
cating endogenous endothelial ecNOS activity. Spotty blue stain (arrow) caused by endoge-
nous NOS activity of vasa vasorum is also seen at adventitial layer. Original magnification, ´3.
b, Mock transfected vein graft as a control. Almost no blue signal, except for adventitial spots
(arrow), is evident. Original magnification, ´12. c, Bovine ecNOS cDNA-transferred canine
vein graft. Intense blue stain is recognized in all layers of graft. Original magnification, ´12.
provided by Dr. R. D. Palmiter (placF; University of
Washington, Seattle).31 The full length of the
nuclear-targeted lac Z gene was inserted down-
stream of the chicken b-actin promoter, named
pAct-NLS-lac Z. The full-length bovine ecNOS
cDNA (3.7 kb; kindly provided by T. Michael,
Harvard Medical School) was from a BlueScript II
SK+ vector by restriction enzyme digestion with
EcoRI and was then ligated into the EcoRI cloning
site of the pUC-CAGGS expression vector, down-
stream of the CAG hybrid promoter (human
cytomegalovirus immediate early enhance/chicken,
b-actin promoter and rabbit, and b-globin polyA).24
Preparation of HVJ-liposomes
All procedures for the preparation of HVJ-lipo-
somes were as described previously.25 Briefly, high-
mobility group-1 nuclear protein (HMG-1, Wako
Pure Chemical Industries, Ltd., Osaka) and plasmid
DNA were complexed in balanced salt saline (BSS;
140 mmol/L NaCl, 5.4 mmol/L KCl, 10 mmol/L
Tris-HCl, pH 7.6) and were entrapped in the lipo-
some film containing phosphatidylserine (sodium
salt), phosphatidylcholine, and cholesterol (from
Sigma, St. Louis). Purified HVJ (Z strain) inactivat-
ed by ultraviolet irradiation was added to the lipo-
some suspension. The HVJ-liposomes were stored at
4° C and were used for transfection studies within a
few days.
In vivo gene transfer and grafting procedures
After exposing femoral veins, pAct-NLS-lac Z,
pUC-CAGGS-ecNOS, or control vector plasmid
without inserted cDNA encapsulated in the HVJ-
liposomes were infused intraluminally and incubated
for 10 minutes at room temperature under a dis-
tending pressure of 100 mm Hg. This vein was
implanted as a reversed vein graft in an end-to-end
fashion to the ipsilateral femoral artery previously
subjected to or not subjected to poor distal runoff.
X-Gal staining for b-galactosidase activity
The host femoral artery was dissected gently and
carefully and was cannulated with an 18-gauge
catheter. The vessel segments were rinsed with nor-
mal saline solution for 10 minutes and were perfused
with 2% formaldehyde/0.25% glutaraldehyde (v/v)
for 10 minutes at 150 mm Hg positive pressure in
vivo, then additional fixation was applied for 10
minutes. The arterial segments were incubated in
the X-Gal staining solution (0.2% v/v 5-bromo-4-
chloro-3-indolyl-b-D-galactoside (Nakarai Tasque
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Fig. 4. Light microscopic features of midportion of vein grafts. Light microscopic findings
indicated endothelial cell nitric oxide synthase (ecNOS; a) gene-transferred, buffer-treated (b),
or mock-transfected (c) canine vein grafts implanted under conditions of poor runoff. Four
weeks after gene transfer and graft implantation, the grafts were perfusion-fixed, harvested, and
embedded in paraffin. Five mm sections were examined under a light microscope. ecNOS gene-
transferred vein graft (a) shows greater reduced neointimal area (n, arrows) than seen in buffer-
treated (b, arrows) or mock-transfected (c, arrows) vein grafts. lu, lumen; ad, adventitia.
Elastica van Gieson’s staining. Original magnification, ´100.
Table I. Hemodynamic data
Flow rate t-variation
Group (ml/min; n = 4) (dyne/cm2; n = 4)
NOS 10.9 ± 0.8 42.1 ± 11.8
pUC 10.7 ± 1.0 49.1 ± 9.4
BSS 10.5 ± 0.5 40.9 ± 9.7
Untreated control 66.4 ± 10.2* 190.1 ± 30.6*
(n = 9)
All values are expressed as mean ± SEM.
*p < 0.01 vs all groups.
Inc., Kyoto), 1 mmol/L MgCl2, 150 mmol/L
NaCl, 3.3 mmol/L K4Fe(CN)6, 3.3 mmol/L
K3Fe(CN)6, 60 mmol/L Na2HPO4 and 40
mmol/L NaH2PO4) for 12 hours at 37° C. The X-
Gal–stained vein grafts were then returned in a
formaldehyde/glutaraldehyde fixative. The X-
Gal–stained vessels were grossly examined and pho-
tographed through a Zeiss Stemi 2000-C dissecting
microscope, then were sectioned into four or five
serial segments at 5 mm intervals. These sections
were embedded in OCT compound, and 5 mm thick
cryostat sections stained with nuclear fast red were
examined with light microscopy.
Immunohistochemical analysis
Rabbit antibovine ecNOS polyclonal antibody
(Wako Pure Chemicals) was the primary antibody
used. The gene-transferred canine vein grafts that
were fixed in neutralized 10% formaldehyde and
embedded in paraffin were sectioned for 5 mm and
then deparaffinized. After blocking with 3% skim milk
for 30 minutes and incubation with primary antibody
for 1 hour, the cells were washed with 0.01 mol/L
phosphate-buffered saline solution and then reacted
with biotinylated goat antirabbit immunoglobulin G
(Histofine kit, Nichirei Co., Tokyo). Thirty minutes
later, the sections were treated with the avidin-biotin-
peroxidase complex (Histofine kit) for 15 minutes at
room temperature. Reaction products were devel-
oped in 3,3-diaminobenzidine tetrahydrochloride
containing 0.1% H2O2. As negative controls, nonim-
munized rabbit serum instead of primary antibody
and pUC-CAGGS vector plasmid–transferred vein
grafts were used.
NADPH diaphorase staining
A total of nine vein grafts (untreated control, n =
3; mock transfection, n = 3; and ecNOS gene trans-
fection, n = 3, respectively) were subjected to
NADPH assay to detect in situ NO production. On
day 4 after gene transfer, vein grafts were perfused
with saline solution and harvested. Soon after har-
vesting, the tissue segments were reacted with
NADPH diaphorase solution (1 mmol/L NADPH,
0.2 mmol/L nitroblue tetrazolium, 0.1 mol/L Tris-
HCl, pH 7.2, 0.2% Triton-X100) for 30 minutes at
37° C, as described.32 The reaction was stopped
using neutralized 10% formaldehyde, the preparation
was cut into the three to five segments, and the seg-
ments were examined under a dissecting microscope.
Morphometric analysis
Four weeks after gene transfection the dogs were
killed, and vein grafts taken from the midportion
were perfusion-fixed with neutralized 10% formalde-
hyde. The graft was cut into five segments at 5
mmol/L intervals, which then were embedded in
paraffin, sectioned to 5 mm, and subsequently
processed for light microscopy (hematoxylin-eosin
and elastica van Gieson’s staining). Intimal thicken-
ing was measured by two different methods using
both an ocular cytometer placed on the ocular lens
of a light microscope (eight-point method) and an
image analyzer (computer method). For the eight-
point method, intimal thickness (mm) was measured
in a randomly selected eight views per section.18 The
mean value of eight values was considered to be the
intimal thickness of one section, then the average of
the five sections of each graft (n = 4) was recorded
as the degree of intimal thickening. A Nikon
Cosmozone image analyzer was also used to quanti-
fy the square of the neointimal area (mm2), and the
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Fig. 5. Quantitative analyses of intimal thickening of
canine vein grafts. Two different methods were used. Four
weeks after gene transfection, the grafts were dissected
gently, perfusion-fixed, and embedded in paraffin. We
then measured 5 mm of five interval sections per vessel seg-
ment, stained with elastica van Gieson’s stain. a,
Measurements using an ocular cytometer placed on ocular
lens of light microscope (eight-point method). b,
Measurements using image analyzer (computer method).
Both quantifications clarified that ecNOS gene transfer
significantly reduced the neointimal lesion, compared with
findings with buffer treatment and mock transfer.
average of the five sections of each graft (n = 4) was
considered the intimal area.33 These values were
subjected to statistical analyses, as described below.
Statistical analyses
The results are expressed as the mean ± SEM. A
statistical evaluation of the data was made by analy-
sis of variance. If the value was statistically signifi-
cant, the post hoc test for multiple comparisons
(Fischer’s protected least significant difference) was
used to identify differences among the groups. The
values were considered to be statistically significant
when the p value was less than 0.05.
RESULTS
All of the grafts (n = 32) were patent at the time
of excision, 4 days or 4 weeks after the operation.
Confirmation of gene transfer to vein grafts
Nuclear-targeted lac Z gene transfer to canine
femoral vein grafts. To determine the appropriate
distending pressure for highly efficient gene transfer
to the canine vein graft, we examined several pres-
sures (very weak, almost 0 mm Hg, n = 1; 100 mm
Hg, n = 3; and 200 mm Hg, n = 1, respectively)
using pAct-NLS-lac Z.
At a weak, positive, nonmeasurable pressure, X-
Gal–positive stain was rarely evident at the luminal
surface of the vein grafts 4 days after gene transfer
(data not shown). On the other hand, 100 mm Hg
of distending positive pressure exhibited a diffuse,
symmetrical, and intense blue stain all over the graft
segment, but was not evident at the host artery (Fig.
1, a and b). Light microscopic examination of X-
Gal–stained graft segments showed frequent blue
signals at medial and adventitial layers (Fig. 1, c).
Interestingly, the microscopic pattern of the X-
Gal–positive cells in the vein graft appeared to be
mainly in the outer media and adventitia and was rel-
atively sparse in the inner media (Fig. 1, c). The vein
graft incubated under a higher distending pressure
(200 mm Hg) showed a disrupted medial architec-
ture and extended loss of medial smooth muscle
cells by light microscopy. The X-Gal–positive area
had a diffuse patchy distribution (data not shown).
Immunohistochemical detection of bovine
ecNOS protein in canine vein grafts. Distribution
of bovine ecNOS protein in the canine femoral vein
grafts was examined with immunohistochemical
analysis, using a rabbit antibovine ecNOS polyclon-
al antibody that does not cross-react with inducible
or brain-type NOS.
Four days after the gene transfer, bovine ecNOS
was frequently evident in the outer media and adven-
titia (Fig. 2, a) and relatively sparse in the inner media
(Fig. 2, a), whereas positive signals were not seen in
serial sections in case of treatment with nonimmu-
nized rabbit serum (Fig. 2, b). The distribution of the
ecNOS-positive cells was similar to that in X-Gal–pos-
itive cells after lac Z gene transfer, as described above.
Moreover, vein grafts with a transferred pUC-
CAGGS control vector for mock transfection showed
no apparent positive signals, in any layer (Fig. 2, c).
NOS activity in gene-transferred canine
femoral vein grafts. To determine NOS activity
related to the exogenously transduced recombinant
ecNOS gene, an ex vivo NADPH assay was per-
formed.
Untreated canine femoral vein and mock trans-
fected vein graft showed a weak positive blue stain
on the luminal surface, attributed to de novo
endothelium (Fig. 3, a and b). A spotty blue stain
was seen in the adventitial layer, probably as a result
of NOS activity in the vasa vasorum, in both
untreated and mock transfected vessel segments
(Fig. 3, a and b), the same as in the case of the
ecNOS gene-transferred vein graft (Fig. 3, c). On
the other hand, an intense blue stain was observed in
all layers of the bovine ecNOS gene-transferred vein
grafts 4 days after implantation (Fig 3, c).
Inhibition of intimal thickening of vein grafts
under poor runoff conditions
Hemodynamic data. In the limbs with poor
runoff, the mean blood flow and t-variation among
the three groups (each group, n = 4) were compara-
ble (Table I) but significantly lower than that seen in
the normal runoff group (n = 9; 66.4 ± 10.2
ml/min, 190.1 ± 30.6 dyne/cm2).
Inhibitory effect of ecNOS gene transfer on
neointimal formation under poor runoff condi-
tions. Four weeks after gene transfer, neointimal
lesions in the vein grafts implanted under conditions
of poor runoff were examined under a light micro-
scope. Buffer-treated or mock-transfected vein grafts
formed a thick neointima (Fig. 4, b and c), whereas
ecNOS gene transferred to a reduction in the neoin-
timal area (Fig. 4, a). Quantitative analysis demon-
strated approximately a 50% reduction in the neoin-
timal area, as quantified by two different methods
(Fig. 5). The neointimal size of the ecNOS gene-
transferred vein grafts measured by the eight-point
method was significantly smaller (90.0 ± 7.6 mm; n
= 4; p < 0.01) than findings in mock-transfected or
buffered saline solution (BSS)–treated grafts (193 ±
15.8 mm and 195.8 ± 25.7 mm; n = 4; respectively).
Moreover, a computer method plus use of an image
analyzer showed a similar reduction rate in the
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ecNOS group (1.18 ± 0.07 mm2; n = 4; p < 0.01) in
comparison with findings in mock-transfer or BSS
groups (2.62 ± 0.48 mm2 and 2.65 ± 0.22 mm2; n
= 4; p < 0.01).
DISCUSSION
Grafting with an autologous vein as a vascular
substitute in the treatment of peripheral arterial
occlusions is the surgical procedure that currently
yields the best long-term results.1 However, late
graft failure is still a significant problem, particularly
in cases of poor runoff vessels.2,3 Hemodynamic fac-
tors such as a low flow velocity and low shear stress
result in progression of late graft failure because of
intimal thickening.4-7
In previous studies, we classified into five types
electromagnetically measured blood flow waveforms
at reconstructive surgery. We noted a close relation-
ship between the ultimate results of the arterial
reconstruction and the intraoperative blood flow
waveforms.6 Grafts with a type 0 or I flow wave pat-
tern (normal flow group, characterized by steep
acceleration and deceleration) had a good long-term
patency rate. In grafts with a type II, III, or IV flow
waveform patterns (abnormal flow group, character-
ized by a gentle sloping), graft failure was more fre-
quent than in the normal flow group. In the present
experiment, we used a poor-runoff model in the
canine femoral artery,19 which is similar to a human
patient with peripheral vascular disease under condi-
tions of poor runoff. Intimal thickening of the auto-
genous vein graft was found to be significantly thick-
er than that in the control group.19
The relationship between endothelial cells and
the development of intimal hyperplasia is critical.
Endothelial cells release growth factors and heparin-
like compounds, which likely have a major influence
on surrounding cells and also aid in maintaining
normal vessel wall homeostasis.34-37 Intimal hyper-
plasia is the result of complex interactions among
platelets, leukocytes, and smooth muscle cells, all of
which are affected by NO.38,39 We and other inves-
tigators reported a reduced production of NO in
experimental autogenous vein grafts.15-18
On the other hand, the enhanced EDRF pro-
duction caused by L-arginine22,23 or eicosapen-
taenoic acid40 reduced the degree of intimal thick-
ening in the vein grafts. The administration of L-
arginine, a precursor of NO formation,8 will reverse
defects in NO activity and also reduce the develop-
ment of proliferative atherosclerotic lesions.41 Tarry
and Makhoul42 demonstrated that L-arginine sup-
plementation enhances NO production at the site of
vascular healing and reduces intimal hyperplasia after
balloon angioplasty. In addition, in rabbit vein grafts
L-arginine reduced experimental vein graft intimal
hyperplasia.23 L-arginine supplementation enhances
NO production in the endothelium and may thus
inhibit the degree of intimal hyperplasia in vein
grafts in hypercholesterolemic animal models. A
relationship may exist between NO and intimal
thickening in vein grafts.43
Regarding gene transfer to vein grafts, there are
reports that describe successful recombinant gene
expression. Chen et al.44 reported that recombinant
adenovirus carrying lac Z of a soluble form of a vas-
cular cell adhesion molecule gene could achieve
highly efficient gene transfer, using an ex vivo incu-
bation technique. Similar to adenovirus, HVJ-lipo-
somes can serve as a appropriate candidate for genet-
ic modification of the vein graft, as shown by Mann
et al.,45 who used antisense oligonucleotides. We
find no documentation concerning HVJ-lipo-
some–mediated gene transfer and recombinant gene
expression in vein grafts. While recognizing differ-
ences in experimental conditions, our present study
does suggest that HVJ-liposomes may be able to
serve as an effective gene-transfer vector system. In
addition, in the present study we demonstrated an
interesting distribution of cells with expression of
recombinant genes in the canine vein graft. Two dif-
ferent genes showed similar results and were mainly
distributed in the outer media and adventitia, yet
were sparse in the inner media. The exact reason is
unknown; however, it is possible that medial smooth
muscle cells, especially in the inner media in the vein
graft, are injured under conditions such as high blood
pressure. It may also be that NO induced by the trans-
ferred ecNOS gene extends to surrounding cells and
may affect proliferation in a paracrine manner, the
result being suppression of intimal thickening.
The striking evidence obtained in the present
study is that gene transfer of ecNOS inhibited inti-
mal hyperplasia in canine vein grafts. To achieve a
therapeutic outcome in cases of graft neointimal
thickening, dietary and systemic administration of
NO-producing agents does not seem to be practical,
and systemic side effects occur. In vivo gene transfer
to the local vessel segment may provide an appropri-
ate strategy for reducing graft stenosis. We used the
HVJ-liposome–mediated gene transfer technique
and clarified that this vector system achieved at least
2 weeks of foreign gene expression in the rabbit
carotid arteries.25 In canine vein grafts, most BrdU-
labeled proliferating vascular smooth muscle cells
disappeared within 2 weeks.46 Therefore, HVJ-lipo-
somes are putative candidates for use in gene thera-
py to prevent late graft failure.
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NO, a multifunctional substance in the blood
vessel wall, is a vasodilator8 and an inhibitor of
endothelium-leukocyte interaction,10 platelet aggre-
gation,11,12 and vascular smooth muscle cell prolif-
eration.14 Moreover, NO induces vascular smooth
muscle cell apoptosis.47 NO overproduction
induced by ecNOS gene transfer may lead to reduc-
tion in the neointimal area. Clinical trials will aim to
clarify the precise mechanism of NO in inhibiting
smooth muscle cell proliferation in vivo, the precise
gene-transfer efficiency, and the vector-induced tox-
icity to human vein grafts.
CONCLUSION
We suppressed the neointimal lesion of canine
vein grafts implanted under conditions of poor
runoff using HVJ-liposome–mediated ecNOS gene
transfer. ecNOS gene transfer warrants further atten-
tion to prevent late graft failure after various bypass
surgeries.
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